Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;10(3):462–472. doi: 10.1111/j.1750-3639.2000.tb00278.x

The Role of Mitochondria in the Pathogenesis of Neurodegenerative Diseases

Giovanni Manfredim 1,✉, M Flint Beal 1
PMCID: PMC8098288  PMID: 10885665

Abstract

A growing body of evidence indicates that mitochondrial dysfunction may play an important role in the pathogenesis of many neurodegenerative disorders. Because mitochondrial metabolism is not only the principal source of high energy intermediates, but also of free radicals, it has been suggested that inherited or acquired mitochondrial defects could be the cause of neuronal degeneration as a consequence of energy defects and oxidative damage. Mitochondrial respiratory chain dysfunction has been reported in association with primary mitochondrial DNA abnormalities, and also as a consequence of mutations in nuclear genes directly involved in mitochondrial functions, such as SURF1, frataxin, and paraplegin.

Defects of oxidative phosphorylation and increased free radical production have also been observed in diseases that are not due to primary mitochondrial abnormalities. In these cases, the mitochondrial dysfunction is likely to be an epiphenomenon, which, nevertheless, could be of importance in precipitating a cascade of events leading to cell death. In either case, understanding the role of mitochondria in the pathogenesis of neurodegenerative diseases could be important for the development of therapeutic strategies in these disorders.

Full Text

The Full Text of this article is available as a PDF (91.7 KB).

References

  • 1. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72: 971–983. [DOI] [PubMed] [Google Scholar]
  • 2. Agsteribbe E, Huckriede A, Veenhuis M, Ruiters MH, Niezen‐Koning KE, Skjeldal OH, Skullerud K, Gupta RS, Hallberg R, Van Diggelen OP, et al. (1993) A fatal, systemic mitochondrial disease with decreased mitochondrial enzyme activities, abnormal ultrastructure of the mitochondria and deficiency of heat shock protein 60. Biochem Biophys Res Commun 193:146–154. [DOI] [PubMed] [Google Scholar]
  • 3. Albers DS, Augood SJ, Martin DM, Standaert DG, Vonsattel JP, Beal MF (1999) Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy. J Neurochem 73: 881–884. [DOI] [PubMed] [Google Scholar]
  • 4. Albers DS, Augood SJ, Park LC, Browne SE, Martin DM, Adamson J, Hutton M, Standaert DG, Vonsattel JP, Gibson GE, Beal MF (2000) Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment. J Neurochem 74: 878–881. [DOI] [PubMed] [Google Scholar]
  • 5. Babcock M, De Silva D, Oaks R, Davis‐Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276: 1709–1712. [DOI] [PubMed] [Google Scholar]
  • 6. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez‐Tur J, Hardy J, Lynch T, Bigio E, Hutton M (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8: 711–715. [DOI] [PubMed] [Google Scholar]
  • 7. Baracca A, Barogi S, Carelli V, Lenaz G, Solaini G (2000) Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a. J Biol Chem 275: 4177–4182. [DOI] [PubMed] [Google Scholar]
  • 8. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB (1996) Inhibition of N‐acetylaspartate production: implications for 1 H MRS studies in vivo. Neuroreport 7:1397–1400. [PubMed] [Google Scholar]
  • 9. Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT (1993) Age‐dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61:1147–1150. [DOI] [PubMed] [Google Scholar]
  • 10. Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB (1994) Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol 36: 882–888. [DOI] [PubMed] [Google Scholar]
  • 11. Bindoff LA, Birch‐Machin M, Cartlidge NE, Parker WD, Jr. , Turnbull DM (1989) Mitochondrial function in Parkinson's disease. Lancet 2: 49. [DOI] [PubMed] [Google Scholar]
  • 12. Bonilla E, Tanji K, Hirano M, Vu TH, DiMauro S, Schon EA (1999) Mitochondrial involvement in Alzheimer's disease. Biochim Biophys Acta 1410:171–182. [DOI] [PubMed] [Google Scholar]
  • 13. Bourgeron T, Rustin P, Chretien D, Birch‐Machin M, Bourgeois M, Viegas‐Pequignot E, Munnich A, Rotig A (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144–149. [DOI] [PubMed] [Google Scholar]
  • 14. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AH (2000) Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9: 275–282. [DOI] [PubMed] [Google Scholar]
  • 15. Briones P, Vilaseca MA, Ribes A, Vernet A, Lluch M, Cusi V, Huckriede A, Agsteribbe E (1997) A new case of multiple mitochondrial enzyme deficiencies with decreased amount of heat shock protein 60. J Inherit Metab Dis 20: 569–577. [DOI] [PubMed] [Google Scholar]
  • 16. Browne SE, Bowling AC, Baik MJ, Gurney M, Brown RH, Jr. , Beal MF (1998) Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J Neurochem 71:281–287. [DOI] [PubMed] [Google Scholar]
  • 17. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41: 646–653. [DOI] [PubMed] [Google Scholar]
  • 18. Bu XD, Rotter JI (1991) X chromosome‐linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci USA 88:8198–8202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P‐type ATPase similar to the Menkes gene. Nat Genet 5: 327–337. [DOI] [PubMed] [Google Scholar]
  • 20. Campos Y, Martin MA, Rubio JC, Solana LG, Garcia‐Benayas C, Terradas JL, Arenas J (1997) Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial DNA. Neurology 49: 595–597. [DOI] [PubMed] [Google Scholar]
  • 21. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P, Authier FJ, Durr A, Mandel JL, Vescovi A, Pandolfo M, Koenig M (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6: 1771–1780. [DOI] [PubMed] [Google Scholar]
  • 22. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271: 1423–1427. [DOI] [PubMed] [Google Scholar]
  • 23. Carri MT, Ferri A, Battistoni A, Famhy L, Gabbianelli R, Poccia F, Rotilio G (1997) Expression of a Cu, Zn super‐oxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH‐SY5Y cells. FEBS Lett 414: 365–368. [DOI] [PubMed] [Google Scholar]
  • 24. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, Durr A, Fontaine B, Ballabio A (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclearencoded mitochondrial metalloprotease. Cell 93: 973–983. [DOI] [PubMed] [Google Scholar]
  • 25. Chalmers RM, Schapira AH (1999) Clinical, biochemical and molecular genetic features of Leber's hereditary optic neuropathy. Biochim Biophys Acta 1410:147–158. [DOI] [PubMed] [Google Scholar]
  • 26. Chamberlain S, Shaw J, Rowland A, Wallis J, South S, Nakamura Y, von Gabain A, Farrall M, Williamson R (1988) Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature 334: 248–250. [DOI] [PubMed] [Google Scholar]
  • 27. Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, Prelle A, Fortunato F, Zeviani M, Napoli L, Bresolin N, Moggio M, Ausenda CD, Taanman JW, Scarlato G (1998) Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 43: 110–116. [DOI] [PubMed] [Google Scholar]
  • 28. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41: 277–281. [DOI] [PubMed] [Google Scholar]
  • 29. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD, Jr. (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late‐onset Alzheimer disease. Proc Natl Acad Sci USA 94: 4526–4531. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 30. De Michele G, De Fusco M, Cavalcanti F, Filla A, Marconi R, Volpe G, Monticelli A, Ballabio A, Casari G, Cocozza S (1998) A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet 63:135–139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. De Vries DD, Van Engelen BG, Gabreels FJ, Ruitenbeek W, Van Oost BA (1993) A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 34: 410–412. [DOI] [PubMed] [Google Scholar]
  • 32. De Vries DD, Went LN, Bruyn GW, Scholte HR, Hofstra RM, Bolhuis PA, Van Oost BA (1996) Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 58: 703–711. [PMC free article] [PubMed] [Google Scholar]
  • 33. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel SE, Lees AJ, Schapira AH, et al. (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35: 38–44. [DOI] [PubMed] [Google Scholar]
  • 34. Di Monte DA, Harati Y, Jankovic J, Sandy MS, Jewell SA, Langston JW (1994) Muscle mitochondrial ATP production in progressive supranuclear palsy. J Neurochem 62: 1631–1634. [DOI] [PubMed] [Google Scholar]
  • 35. DiMauro S, De Vivo DC (1996) Genetic heterogeneity in Leigh syndrome. Ann Neurol 40: 5–7. [DOI] [PubMed] [Google Scholar]
  • 36. Glerum DM, Shtanko A, Tzagoloff A (1996) SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae. J Biol Chem 271: 20531–20535. [DOI] [PubMed] [Google Scholar]
  • 37. Gu M, Cooper JM, Taanman JW, Schapira AH (1998) Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease. Ann Neurol 44: 177–186. [DOI] [PubMed] [Google Scholar]
  • 38. Gu M, Gash MT, Mann VM, Javoy‐Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39: 385–389. [DOI] [PubMed] [Google Scholar]
  • 39. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772–1775. [DOI] [PubMed] [Google Scholar]
  • 40. Harding AE (1981) Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104: 589–620. [DOI] [PubMed] [Google Scholar]
  • 41. Harding AE (1981) Genetic aspects of autosomal dominant late onset cerebellar ataxia. J Med Genet 18: 436–441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 30: 563–571. [DOI] [PubMed] [Google Scholar]
  • 43. Hevner RF, Wong‐Riley MT (1993) Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J Neurosci 13:1805–1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Hirano M, Shtilbans A, Mayeux R, Davidson MM, DiMauro S, Knowles JA, Schon EA (1997) Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus‐embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 94: 14894–14899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Hofhaus G, Johns DR, Hurko O, Attardi G, Chomyn A (1996) Respiration and growth defects in transmitochondrial cell lines carrying the 11778 mutation associated with Leber's hereditary optic neuropathy. J Biol Chem 271: 13155–13161. [DOI] [PubMed] [Google Scholar]
  • 46. Holt IJ, Harding AE, Petty RK, Morgan‐Hughes JA (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46: 428–433. [PMC free article] [PubMed] [Google Scholar]
  • 47. Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML (1991) A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 48: 1147–1153. [PMC free article] [PubMed] [Google Scholar]
  • 48. Janetzky B, Hauck S, Youdim MB, Riederer P, Jellinger K, Pantucek F, Zochling R, Boissl KW, Reichmann H (1994) Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 169: 126–128. [DOI] [PubMed] [Google Scholar]
  • 49. Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43: 2689–2695. [DOI] [PubMed] [Google Scholar]
  • 50. Jin H, May M, Tranebjaerg L, Kendall E, Fontan G, Jackson J, Subramony SH, Arena F, Lubs H, Smith S, Stevenson R, Schwartz C, Vetrie D (1996) A novel X‐linked gene, DDP, shows mutations in families with deafness (DFN‐1), dystonia, mental deficiency and blindness. Nat Genet 14: 177–180. [DOI] [PubMed] [Google Scholar]
  • 51. Johns DR, Neufeld MJ, Park RD (1992) An ND‐6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 187: 1551–1557. [DOI] [PubMed] [Google Scholar]
  • 52. Jun AS, Brown MD, Wallace DC (1994) A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 91: 6206–6210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Kimura S, Ohtuki N, Nezu A, Tanaka M, Takeshita S (1997) Clinical and radiologic improvements in mitochondrial encephalomyelopathy following sodium dichloroacetate therapy. Brain Dev 19: 535–540. [DOI] [PubMed] [Google Scholar]
  • 54. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah‐Daouk R, Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5: 347–350. [DOI] [PubMed] [Google Scholar]
  • 55. Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G (1999) Human deafness dystonia syndrome is a mitochondrial disease. Proc Natl Acad Sci USA 96: 2141–2146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Kong J, Xu Z (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18: 3241–3250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF (1997) Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 41: 160–165. [DOI] [PubMed] [Google Scholar]
  • 58. Koutnikova H, Campuzano V, Koenig M (1998) Maturation of wildtype and mutated frataxin by the mitochondrial processing peptidase. Hum Mol Genet 7:1485–1489. [DOI] [PubMed] [Google Scholar]
  • 59. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alphasynuclein in Parkinson's disease. Nat Genet 18: 106–108. [DOI] [PubMed] [Google Scholar]
  • 60. Lenaz G (1998) Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1366:53–67. [DOI] [PubMed] [Google Scholar]
  • 61. Leonhard K, Stiegler A, Neupert W, Langer T (1999) Chaperone‐like activity of the AAA domain of the yeast Yme1 AAA protease. Nature 398: 348–351. [DOI] [PubMed] [Google Scholar]
  • 62. Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, Trijbels F, Hamel B, Mullaart R, van den Heuvel L (1998) The first nuclear‐encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 63: 1598–1608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Lombes A, Nakase H, Tritschler HJ, Kadenbach B, Bonilla E, DeVivo DC, Schon EA, DiMauro S (1991) Biochemical and molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Neurology 41: 491–498. [DOI] [PubMed] [Google Scholar]
  • 64. Lutsenko S, Cooper MJ (1998) Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci USA 95: 6004–6009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Majander A, Huoponen K, Savontaus ML, Nikoskelainen E, Wikstrom M (1991) Electron transfer properties of NADH: ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett 292: 289–292. [DOI] [PubMed] [Google Scholar]
  • 66. Manfredi G, Gupta N, Vazquez‐Memije ME, Sadlock JE, Spinazzola A, De Vivo DC, Schon EA (1999) Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem 274: 9386–9391. [DOI] [PubMed] [Google Scholar]
  • 67. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115: 333–342. [DOI] [PubMed] [Google Scholar]
  • 68. Mansouri A, Gaou I, Fromenty B, Berson A, Letteron P, Degott C, Erlinger S, Pessayre D (1997) Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology 113: 599–605. [DOI] [PubMed] [Google Scholar]
  • 69. Mashkevich G, Repetto B, Glerum DM, Jin C, Tzagoloff A (1997) SHY1, the yeast homolog of the mammalian SURF‐1 gene, encodes a mitochondrial protein required for respiration. J Biol Chem 272:14356–14364. [DOI] [PubMed] [Google Scholar]
  • 70. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36: 747–751. [DOI] [PubMed] [Google Scholar]
  • 71. Montermini L, Rodius F, Pianese L, Molto MD, Cossee M, Campuzano V, Cavalcanti F, Monticelli A, Palau F, Gyapay G, et al. (1995) The Friedreich ataxia critical region spans a 150‐kb interval on chromosome 9q13. Am J Hum Genet 57:1061–1067. [PMC free article] [PubMed] [Google Scholar]
  • 72. Morten KJ, Caky M, Matthews PM (1998) Stabilization of the pyruvate dehydrogenase E1 alpha subunit by dichloroacetate. Neurology 51: 1331–1335. [DOI] [PubMed] [Google Scholar]
  • 73. Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 63: 2179–2184. [DOI] [PubMed] [Google Scholar]
  • 74. Naito E, Ito M, Yokota I, Saijo T, Matsuda J, Osaka H, Kimura S, Kuroda Y (1997) Biochemical and molecular analysis of an X‐linked case of Leigh syndrome associated with thiamin‐responsive pyruvate dehydrogenase deficiency. J Inherit Metab Dis 20: 539–548. [DOI] [PubMed] [Google Scholar]
  • 75. Newman NJ, Lott MT, Wallace DC (1991) The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 111: 750–762. [DOI] [PubMed] [Google Scholar]
  • 76. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH‐linked oxidation in brain mitochondria by 1‐methyl‐4‐ phenyl‐pyridine, a metabolite of the neurotoxin, 1‐methyl‐4‐phenyl‐ 1,2,5,6‐tetrahydropyridine. Life Sci 36: 2503–2508. [DOI] [PubMed] [Google Scholar]
  • 77. Ojaimi J, Masters CL, McLean C, Opeskin K, McKelvie P, Byrne E (1999) Irregular distribution of cytochrome c oxidase protein subunits in aging and Alzheimer's disease. Ann Neurol 46: 656–660. [PubMed] [Google Scholar]
  • 78. Oostra RJ, Van Galen MJ, Bolhuis PA, Bleeker‐Wage‐makers EM, Van den Bogert C (1995) The mitochondrial DNA mutation ND6°14, 484C associated with leber hereditary optic neuropathy, leads to deficiency of complex I of the respiratory chain. Biochem Biophys Res Commun 215:1001–1005. [DOI] [PubMed] [Google Scholar]
  • 79. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, Krishna S, Walker W, Selby J, Glerum DM, Coster RV, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Hirano M, DiMauro S, Schon EA (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23: 333–337. [DOI] [PubMed] [Google Scholar]
  • 80. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha‐synuclein gene identified in families with Parkinson's disease. Science 276: 2045–2047. [DOI] [PubMed] [Google Scholar]
  • 81. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, Christodoulou J, Thorburn DR (1996) Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 39: 343–351. [DOI] [PubMed] [Google Scholar]
  • 82. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59–62. [DOI] [PubMed] [Google Scholar]
  • 83. Rotig A, De Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P (1997) Aconitase and mitochondrial iron‐sulphur protein deficiency in Friedreich ataxia. Nat Genet 17: 215–217. [DOI] [PubMed] [Google Scholar]
  • 84. Sanchez‐Casis G, Cote M, Barbeau A (1976) Pathology of the heart in Friedreich's ataxia: review of the literature and report of one case. Can J Neurol Sci 3: 349–354. [DOI] [PubMed] [Google Scholar]
  • 85. Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S (1993) The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 34: 827–834. [DOI] [PubMed] [Google Scholar]
  • 86. Sasaki S, Iwata M (1996) Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 47: 535–540. [DOI] [PubMed] [Google Scholar]
  • 87. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823–827. [DOI] [PubMed] [Google Scholar]
  • 88. Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, Stockler‐Ipsiroglu S, van den Heuvel L (1999) Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 21: 260–261. [DOI] [PubMed] [Google Scholar]
  • 89. Sergeant N, Wattez A, Delacourte A (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corti‐cobasal degeneration: tau pathologies with exclusively “exon 10” isoforms. J Neurochem 72:1243–1249. [DOI] [PubMed] [Google Scholar]
  • 90. Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, Johns DR (1999) Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53:1787–1793. [DOI] [PubMed] [Google Scholar]
  • 91. Smith PR, Cooper JM, Govan GG, Harding AE, Schapira AH (1994) Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 122: 80–83. [DOI] [PubMed] [Google Scholar]
  • 92. Sternlieb I (1992) Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease. Hepatology 16: 728–732. [DOI] [PubMed] [Google Scholar]
  • 93. Sternlieb I, Quintana N, Volenberg I, Schilsky ML (1995) An array of mitochondrial alterations in the hepatocytes of Long‐Evans Cinnamon rats. Hepatology 22: 1782–1787. [PubMed] [Google Scholar]
  • 94. Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP, Jr. , Davis RE, Parker WD, Jr. (1997) Cybrids in Alzheimer's disease: a cellular model of the disease Neurology 49: 918–925. [DOI] [PubMed] [Google Scholar]
  • 95. Swerdlow RH, Parks JK, Cassarino DS, Shilling AT, Bennett JP, Jr. , Harrison MB, Parker WD, Jr. (1999) Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochem Biophys Res Commun 261:701–704. [DOI] [PubMed] [Google Scholar]
  • 96. Swerdlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP, Jr. , Davis RE, Parker WD, Jr. (1998) Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 153: 135–142. [DOI] [PubMed] [Google Scholar]
  • 97. Swerdlow RH, Parks JK, Davis JN, 2nd , Cassarino DS, Trimmer PA, Currie LJ, Dougherty J, Bridges WS, Bennett JP, Jr. , Wooten GF, Parker WD (1998) Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann Neurol 44: 873–881. [DOI] [PubMed] [Google Scholar]
  • 98. Taanman JW (1999) The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410:103–123. [DOI] [PubMed] [Google Scholar]
  • 99. Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann Neurol 45: 25–32. [DOI] [PubMed] [Google Scholar]
  • 100. Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann Neurol 47: 80–86. [DOI] [PubMed] [Google Scholar]
  • 101. Tatton WG, Olanow CW (1999) Apoptosis in neurodegen‐erative diseases: the role of mitochondria. Biochim Biophys Acta 1410:195–213. [DOI] [PubMed] [Google Scholar]
  • 102. Tatuch Y, Pagon RA, Vlcek B, Roberts R, Korson M, Robinson BH (1994) The 8993 mtDNA mutation: hetero‐plasmy and clinical presentation in three families. Eur J Hum Genet 2: 35–43. [DOI] [PubMed] [Google Scholar]
  • 103. Tatuch Y, Robinson BH (1993) The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun 192: 124–128. [DOI] [PubMed] [Google Scholar]
  • 104. Tiranti V, Galimberti C, Nijtmans L, Bovolenta S, Perini MP, Zeviani M (1999) Characterization of SURF‐1 expression and Surf‐1p function in normal and disease conditions. Hum Mol Genet 8: 2533–2540. [DOI] [PubMed] [Google Scholar]
  • 105. Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, Zelante L, Gasparini P, Marzella R, Rocchi M, Bayona‐Bafaluy MP, Enriquez JA, Uziel G, Bertini E, Dionisi‐Vici C, Franco B, Meitinger T, Zeviani M (1998) Mutations of SURF‐1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63: 1609–1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Triepels RH, van den Heuvel LP, Loeffen JL, Buskens CA, Smeets RJ, Rubio Gozalbo ME, Budde SM, Mariman EC, Wijburg FA, Barth PG, Trijbels JM, Smeitink JA (1999) Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol 45: 787–790. [DOI] [PubMed] [Google Scholar]
  • 107. van den Heuvel L, Ruitenbeek W, Smeets R, GelmanKohan Z, Elpeleg O, Loeffen J, Trijbels F, Mariman E, De Bruijn D, Smeitink J (1998) Demonstration of a new pathogenic mutation in human complex I deficiency: a 5‐bp duplication in the nuclear gene encoding the 18‐kD (AQDQ) subunit. Am J Hum Genet 62: 262–268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108. Vazquez‐Memije ME, Shanske S, Santorelli FM, KranzEble P, Davidson E, De Vivo DC, DiMauro S (1996) Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis 19: 43–50. [DOI] [PubMed] [Google Scholar]
  • 109. Wadia JS, Chalmers‐Redman RME, Ju WJH, Carlile GW, Phillips JL, Fraser AD, Tatton WG (1998) Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (‐)‐deprenyl. J Neurosci 18: 932–947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJd, Nikoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427–1430. [DOI] [PubMed] [Google Scholar]
  • 111. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD (1997) Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 94: 14900–14905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156: 65–72. [DOI] [PubMed] [Google Scholar]
  • 113. Yao J, Shoubridge EA (1999) Expression and functional analysis of SURF1 in Leigh syndrome patients with cytochrome c oxidase deficiency. Hum Mol Genet 8: 2541–2549. [DOI] [PubMed] [Google Scholar]
  • 114. Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C, Cuthbert AP, Newbold RF, Wang J, Chevrette M, Brown GK, Brown RM, Shoubridge EA (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20: 337–343. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES